Key result
Inferior vena cava filters reduced the risk of subsequent pulmonary embolism by 50% but increased the risk of deep vein thrombosis without affecting overall mortality.
Why the study?
Inferior vena cava filters are widely used to prevent pulmonary embolism, but uncertainty persists regarding their efficacy and safety.
Do inferior vena cava (IVC) filters reduce subsequent pulmonary embolism and mortality in patients at risk of PE?
Meta-Analysis (n=4,204)
Do inferior vena cava (IVC) filters reduce subsequent pulmonary embolism and mortality in patients at risk of PE?
Answers are grounded in this paper and cite their sources.
Captured external expert commentary on this paper, strongest first. Original sources are linked where available.
“The most striking news to come out of the research is how few papers exist. That to me speaks to the need for much more research in this area.”
“The most important message [of the current paper] lies... in the quantity and quality of the evidence that the authors were able to retrieve over an impressive time period spanning no less than 43 years.”
In patients at risk for pulmonary embolism, IVC filters reduce the risk of subsequent PE but increase the risk of DVT, without significantly improving overall or PE-related mortality.
BACKGROUND Inferior vena cava (IVC) filters are widely used for prevention of pulmonary embolism (PE). However, uncertainty persists about their efficacy and safety. OBJECTIVES The authors conducted a systematic review and meta-analysis of the published reports on the efficacy and safety of IVC filters. METHODS The authors searched PubMed, the Cochrane Central Register of Controlled Trials, and ClinicalTrials.gov through October 3, 2016, for randomized controlled trials (RCTs) or prospective controlled observational studies of IVC filters versus none in patients at risk of PE. Inverse variance fixed-effects models with odds ratio (OR) as the effect measure were used for primary analyses. Main outcomes included subsequent PE, PE-related mortality, all-cause mortality, and subsequent deep vein thrombosis (DVT). RESULTS The authors' search retrieved 1,986 studies, of which 11 met criteria for inclusion (6 RCTs and 5 prospective observational studies). Quality of evidence for RCTs was low to moderate. Overall, patients receiving IVC filters had lower risk for subsequent PE (OR: 0.50; 95% confidence interval [CI]: 0.33 to 0.75); increased risk for DVT (OR: 1.70; 95% CI: 1.17 to 2.48); nonsignificantly lower PE-related mortality (OR: 0.51; 95% CI: 0.25 to 1.05); and no change in all-cause mortality (OR: 0.91; 95% CI: 0.70 to 1.19). Limiting the results to RCTs showed similar results. Findings were substantively similar across a wide range of sensitivity analyses. CONCLUSIONS Very few prospective controlled studies, with limited quality of evidence, exist regarding the efficacy and safety of IVC filters. Overall, filters appear to reduce the risk of subsequent PE, increase the risk for DVT, and have no significant effect on overall mortality.
No takes yet. Share an insight, caveat, or question.
Bikdeli et al. (2017) conducted a meta-analysis in Patients at risk of pulmonary embolism (PE) (n=4,204). Inferior vena cava (IVC) filters vs. No IVC filter was evaluated on Subsequent pulmonary embolism (PE) (OR 0.50, 95% CI 0.33 to 0.75). Inferior vena cava filters reduced the risk of subsequent pulmonary embolism by 50% but increased the risk of deep vein thrombosis without affecting overall mortality.
Synapse has enriched 10 related papers. Consider them for comparative context: